Médecins Sans Frontières (MSF) Access Campaign

‘Time for $5’ campaign to deliver 206,937 signatures to US corporation Danaher in Washington, DC, demanding a $5 price for their medical tests

MSF calls for urgent action as governments and donors are failing children with TB

MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens

UN Political Declaration on antimicrobial resistance essential step, but concrete action from governments now critical

Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible

Major advance in the fight against MDR-TB: four new short and effective treatments approved by the WHO

MSF responds to WHO declaring mpox a public health emergency of international concern

Pharmaceutical corporation ViiV must urgently supply HIV drug CAB-LA according to global public health needs

MSF and partners protest medical test maker Cepheid and Danaher at International AIDS Conference

Activists at AIDS2024 Demand: Break Gilead’s Lenacapavir Monopoly Gilead’s Price is 1,000 Times the Target Generic Price for 100% Effective Prevention Shot

MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug

MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa

Get updates in your mailbox

About Médecins Sans Frontières (MSF) Access Campaign

In 1999, in the wake of Médecins Sans Frontières (MSF) being awarded the Nobel Peace Prize, MSF launched the Access Campaign. Its purpose has been to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond.

Contact

Route de Ferney 140 P.O. Box 1224 CH-1211 Geneva 1, Switzerland

+41 79 203 13 02

shailly.gupta@geneva.msf.org

www.msfaccess.org